Menu

Blog

Jun 12, 2020

J&J exec: Our coronavirus vaccine is aiming for a 70% success rate in trials

Posted by in category: biotech/medical

J&J Chief Scientific Officer Dr. Paul Stoffels says the vaccine being produced needs a minimum 70% efficacy to be considered successful.

Leave a reply